GetTopicDetailResponse(id=85f5555832b, topicName=抗磷脂抗體綜合征, introduction=抗磷脂抗體綜合征, content=null, image=null, comments=3, allHits=1289, url=https://h5.medsci.cn/topic?id=55583, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71038, tagList=[TagDto(tagId=71038, tagName=抗磷脂抗體綜合征)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1927195, encodeId=6af5192e195c0, content=<a href='/topic/show?id=85f5555832b' target=_blank style='color:#2F92EE;'>#抗磷脂抗體綜合征#</a>, objectTitle=Mayo Clin Proc：系統(tǒng)性紅斑狼瘡和抗磷脂抗體綜合征患者發(fā)生生物瓣膜血栓的極端病例, objectType=article, longId=300410, objectId=2b63300410f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b63300410f8, replyNumber=0, likeNumber=113, createdTime=2022-07-28, rootId=0, userName=july_975, userId=2726119, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b63300410f8, moduleTitle=Mayo Clin Proc：系統(tǒng)性紅斑狼瘡和抗磷脂抗體綜合征患者發(fā)生生物瓣膜血栓的極端病例, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2b63300410f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927194, encodeId=c6d9192e1943e, content=<a href='/topic/show?id=85f5555832b' target=_blank style='color:#2F92EE;'>#抗磷脂抗體綜合征#</a>, objectTitle=Blood：補體激活與抗磷脂抗體綜合征的血栓形成事件, objectType=article, longId=184612, objectId=642c18461246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642c18461246, replyNumber=0, likeNumber=93, createdTime=2020-05-13, rootId=0, userName=july_975, userId=2726119, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642c18461246, moduleTitle=Blood：補體激活與抗磷脂抗體綜合征的血栓形成事件, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=642c18461246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927193, encodeId=467e192e193ea, content=<a href='/topic/show?id=85f5555832b' target=_blank style='color:#2F92EE;'>#抗磷脂抗體綜合征#</a>, objectTitle=Blood：高風險的抗磷脂抗體綜合征患者不宜用利伐沙班替代華法林抗凝, objectType=article, longId=144629, objectId=1679144629a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1679144629a3, replyNumber=0, likeNumber=107, createdTime=2018-08-22, rootId=0, userName=july_975, userId=2726119, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1679144629a3, moduleTitle=Blood：高風險的抗磷脂抗體綜合征患者不宜用利伐沙班替代華法林抗凝, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1679144629a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
